Twist Bioscience (TWST) is scheduled to report earnings on January 31, 2025. The last reported earnings were for reported on November 18, 2024 for Q4.

GPs say patients who desperately need hospital treatment are increasingly not even making it onto waiting lists. An excerpt of a letter to a GP from Palmerston North Hospital's orthopaedic clinic ...

An excerpt of a letter to a GP from Palmerston North Hospital’s orthopaedic clinic this year – obtained by RNZ – confirms some referrals are being knocked back because of “lack of ...

Twist Bioscience Corporation (NASDAQ:TWST) Q4 2024 Earnings Call Transcript November 18, 2024 Operator: Welcome to Twist Bioscience's 2024 Fourth Quarter Financial Results Conference Call.

Twist Bioscience Corp (NASDAQ:TWST) reported a record quarter in revenue and margin growth, with a 27% year-over-year increase in revenue to $84.7 million. The company achieved a gross margin of ...

Twist Biosciences is headquartered in South San Francisco, CA. The company provides synthetic genes and gene fragments that are used in product development for therapeutics across myriad ...

Adjusted EBITDA of approximately $(20) million with sequential improvements throughout 2025. Price Action: TWST stock is up 12.7% at $41.59 at last check Monday.

Twist Bioscience (TWST) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to loss of $0.81 per share a year ago. These figures ...